What is the most common treatment for lymphoblastic lymphoma?

• A. Immunotherapy
• B. Radiation therapy alone
• C. Combined chemotherapy
• D. Surgery

Answer: (C)

Treating lymphoblastic lymphoma relies on systemic chemotherapy because this disease behaves like a widespread malignancy rather than a localized one. LBL is biologically related to acute lymphoblastic leukemia, so cancer cells are often present in or can spread to bone marrow and central nervous system. This makes killing the malignant cells throughout the body essential, which is best accomplished with multiagent chemotherapy regimens given in cycles. These regimens are designed to attack cells at different stages of the cell cycle and to address sanctuary sites like the CNS, often with intrathecal or CNS-directed therapy.

Radiation therapy alone can control a localized area but doesn’t eradicate microscopic disease elsewhere, so it’s not the standard first-line approach for most patients. Immunotherapy has a role in specific scenarios, such as relapsed or refractory disease, but it is not the typical initial treatment for most cases. Surgery, beyond obtaining a diagnostic biopsy, doesn’t remove systemic disease.

So the most common treatment is combined chemotherapy because it targets disease systemically and offers the best chance for durable remission.